Exoskeleton Partial-Coated Stem Cells for Infarcted Myocardium Restoring

被引:2
|
作者
He, Huihui [1 ]
Yuan, Yuan [2 ]
Wu, Yunhong [1 ]
Lu, Jingyi [1 ]
Yang, Xiaofu [1 ]
Lu, Kejie [1 ]
Liu, An [3 ]
Cao, Zelin [4 ]
Sun, Miao [1 ]
Yu, Mengfei [1 ]
Wang, Huiming [1 ]
机构
[1] Zhejiang Univ, Zhejiang Prov Clin Res Ctr Oral Dis, Engn Res Ctr Oral Biomat & Devices Zhejiang Prov, Sch Med,Stomatol Hosp,Sch Stomatol,Key Lab Oral Bi, Hangzhou 310000, Peoples R China
[2] Zhejiang Univ, Univ Edinburgh Inst, Key Lab Tissue Engn & Regenerat Med Zhejiang Prov, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Orthopaed Surg, Hangzhou 310009, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Clin Med Coll 1, Wenzhou 325035, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
cell partial encapsulation; exoskeletons; inorganic-organic nanobiohybrids; myocardial infarction; stem cells; STIMULI-RESPONSIVE NANOCARRIERS; CARDIAC ENGRAFTMENT; OXIDATIVE STRESS; IN-VIVO; ANGIOGENESIS; REGENERATION; THERAPY; REPAIR; TRANSPLANTATION; MECHANISMS;
D O I
10.1002/adma.202307169
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The integration of abiotic materials with live cells has emerged as an exciting strategy for the control of cellular functions. Exoskeletons consisting ofmetal-organic frameworks are generated to produce partial-coated bone marrow stem cells (BMSCs) to overcome low cell survival leading to disappointing effects for cell-based cardiac therapy. Partially coated exoskeletons can promote the survival of suspended BMSCs by integrating the support of exoskeletons and unimpaired cellular properties. In addition, partial exoskeletons exhibit protective effects against detrimental environmental conditions, including reactive oxygen species, pH changes, and osmotic pressure. The partial-coated cells exhibit increased intercellular adhesion forces to aggregate and adhere, promoting cell survival and preventing cell escape during cell therapy. The exoskeletons interact with cell surface receptors integrin alpha 5 beta 1, leading to augmented biological functions with profitable gene expression alteration, such as Vegfa, Cxcl12, and Adm. The partial-coated BMSCs display enhanced cell retention in infarcted myocardium through non-invasive intravenous injections. The repair of myocardial infarction has been achieved with improved cardiac function, myocardial angiogenesis, proliferation, and inhibition of cell apoptosis. This discovery advances the elucidation of potential molecular and cellular mechanisms for cell-exoskeleton interactions and benefits the rational design and manufacture of next-generation nanobiohybrids. Exoskeletons are generated to produce partial-coated bone marrow stem cells (BMSCs) as a novel biologic formulation with dual-sided characteristics. The exoskeleton side promotes cell viability and targeting, whereas the cell side retains the ability of cell adhesion and external secretion. With the synergism of increased survival, retention, and augmented paracrine secretion, the partial-coated BMSCs exhibit promising heart repair effects.image
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Imaging stem cells implanted in infarcted myocardium
    Zhou, Rong
    Acton, Paul D.
    Ferrari, Victor A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (10) : 2094 - 2106
  • [2] Antibody targeting of stem cells to infarcted myocardium
    Lee, Randall J.
    Fang, Qizhi
    Davol, Pamela A.
    Gu, Yiping
    Sievers, Richard E.
    Grabert, Ryan C.
    Gall, Jonathan M.
    Tsang, Eric
    Yee, Michael S.
    Fok, Hubert
    Huang, Ngan F.
    Padbury, James F.
    Larrick, James W.
    Lum, Lawrence G.
    STEM CELLS, 2007, 25 (03) : 712 - 717
  • [3] Fluorescent conjugated polymer nanovector for in vivo tracking and regulating the fate of stem cells for restoring infarcted myocardium
    Jin, Guorui
    Li, Wenfang
    Song, Fan
    Zhao, Jing
    Wang, Mengqi
    Liu, Qian
    Li, Ang
    Huang, Guoyou
    Xu, Feng
    ACTA BIOMATERIALIA, 2020, 109 : 195 - 207
  • [4] Bone marrow stem cells regenerate infarcted myocardium
    Orlic, D
    Kajstura, J
    Chimenti, S
    Bodine, DM
    Leri, A
    Anversa, P
    PEDIATRIC TRANSPLANTATION, 2003, 7 : 86 - 88
  • [5] Cardiac stem cells repair infarcted scarred myocardium
    Barlucchi, L
    Chimenti, S
    Beltrami, A
    Zias, E
    Leri, A
    Kajstura, J
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2003, 35 (06) : A37 - A37
  • [6] Genetic Modification of Stem Cells for Improved Therapy of the Infarcted Myocardium
    Haider, Husnain Kh
    Mustafa, Anique
    Feng, Yuliang
    Ashraf, Muhammad
    MOLECULAR PHARMACEUTICS, 2011, 8 (05) : 1446 - 1457
  • [7] Transplanted mesenchymal stem cells induce angiogenesis in infarcted myocardium
    Davani, S
    Marandin, A
    Kantelip, B
    Chocron, S
    Tiberghien, P
    Etievent, JP
    Kantelip, JP
    CIRCULATION, 2002, 106 (19) : 549 - 550
  • [8] UTERINE STEM CELLS ARE RECRUITED TO THE INFARCTED MYOCARDIUM FOR CARDIAC REGENERATION
    Hatta, K.
    Xaymardan, M.
    Sun, Z.
    Tsukashita, M.
    Konecny, F.
    Weisel, R. D.
    Li, R.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) : S130 - S131
  • [9] In vivo detection of stem cells grafted in infarcted rat myocardium
    Zhou, R
    Thomas, DH
    Qiao, H
    Bal, HS
    Choi, SR
    Alavi, A
    Ferrari, VA
    Kung, HF
    Acton, PD
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (05) : 816 - 822
  • [10] An in Vivo miRNA Delivery System for Restoring Infarcted Myocardium
    Yang, Huaxiao
    Qin, Xulei
    Wang, Huiyuan
    Zhao, Xin
    Liu, Yonggang
    Wo, Hung-Ta
    Liu, Chun
    Nishiga, Masataka
    Chen, Haodong
    Ge, Jing
    Sayed, Nazish
    Abilez, Oscar J.
    Ding, Dan
    Heilshorn, Sarah C.
    Li, Kai
    ACS NANO, 2019, 13 (09) : 9880 - 9894